Biogen Rises to Record After FDA Approval of Tecfidera MS Pill

Biogen Idec Inc., the fourth- largest U.S. biotechnology company by market value, rose to a record price after the drugmaker won U.S. approval for its first pill for multiple sclerosis, Tecfidera.

http://washpost.bloomberg.com/Story?docId=1376-MK9SWC6S972V01-5RIA4FQNVAUMJPAG14JJBTU2HA